H
HCW Biologics Inc. (HCWB)
NCM – Real vaqt narxi. Valyuta: USD
0.40
+0.03 (6.92%)
Yopilishda: Mar 27, 2026, 4:00 PM EDT
0.42
+0.02 (5.26%)
Bozordan keyin: Mar 27, 2026, 7:56 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
NCM – Real vaqt narxi. Valyuta: USD
0.40
+0.03 (6.92%)
Yopilishda: Mar 27, 2026, 4:00 PM EDT
0.42
+0.02 (5.26%)
Bozordan keyin: Mar 27, 2026, 7:56 PM EDT
HCW Biologics Inc., klinik bosqichdagi biofarmatsevtika kompaniyasi, Qo'shma Shtatlarda surunkali, past darajadagi yallig'lanish va yoshga bog'liq kasalliklar uchun yangi immunoterapiyalarni kashf qilish va ishlab chiqishga qaratilgan. Kompaniyaning asosiy mahsulotlari orasida kimyoterapiyaga chidamli qattiq o'simta saratonini davolash uchun 1-bosqichni va oshqozon osti bezi saratonini davolash uchun 1b/2 bosqichini tugatgan klinik bosqichdagi bifunksional molekula bo'lgan HCW9218; va alopesiya areata kabi autoimmün va yallig'lanishga qarshi kasalliklar uchun 1-bosqichda bo'lgan in'ektsion va interleukin 2 (IL-2) birikma oqsili kompleksi bo'lgan HCW9302 mavjud. Kompaniya, shuningdek, xotira kabi tabiiy killer hujayralari, saraton va patogenlar uchun yangi immunoterapiya bo'lgan HCW9201 va HCW9206; immunitet hujayralari stimulyatori bo'lgan HCW11-006; onkologiya va boshqa senesentsiya bilan bog'liq ko'rsatmalarni davolash uchun immunitet nazorat nuqtasi inhibitörlari bo'lgan HCW11-002 va HCW11-0027; va saratonni davolash uchun birikmalar va immunitet hujayralari vositachilari bo'lgan HCW11-018ni ishlab chiqadi. Kompaniya hujayra terapiyasiga asoslangan davolash usullarini ishlab chiqish uchun Wugen Inc. bilan litsenziya shartnomasiga ega; va preclinical molekulalari uchun WY Biotech Co., Ltd. bilan litsenziya, tadqiqot va qo'shma ishlab chiqish shartnomasiga ega. HCW Biologics Inc. 2018 yilda tashkil etilgan va AQShning Florida shtatidagi Miramar shahrida joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Hing C. Wong Ph.D. | Founder, CEO, Director & Secretary |
| Dr. Peter Rhode Ph.D. | Chief Scientific Officer & VP of Clinical Operations |
| Mr. Lee D. Flowers | Senior Vice President of Business Development |
| Ms. Nicole Valdivieso Esq., J.D. | Vice President of Legal Affairs |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-03-17 | 8-K | hcwb-20260316.htm |
| 2026-03-02 | 8-K | hcwb-20260226.htm |
| 2026-01-09 | S-1 | d783817ds1.htm |
| 2025-12-31 | 8-K | hcwb-20251230.htm |
| 2025-12-19 | DRS | filename1.htm |
| 2025-11-20 | 8-K | hcwb-20251119.htm |
| 2025-11-19 | 8-K | hcwb-20251117.htm |
| 2025-11-18 | 8-K | hcwb-20251117.htm |
| 2025-11-14 | 10-Q | hcwb-20250930.htm |
| 2025-10-16 | 8-K | hcwb-20251013.htm |